181 results on '"Maccagnano Carmen"'
Search Results
2. Active surveillance for non-muscle invasive bladder cancer: A systematic review and pooled-analysis
3. Active Surveillance for Low-Risk Non-Muscle Invasive Bladder Cancer
4. Enhancing the Quality of Transurethral Resection: The Importance of a Complete TURB and the En-Bloc Resection
5. US Contrast Media in Prostatic Disease
6. HistoScanning
7. Role of Imaging and Biopsy to Assess Local Recurrence After Definitive Treatment for Prostate Carcinoma
8. Ultrasound-Guided Treatment of Prostate Cancer: High-Intensity Focused Ultrasound
9. Interventional Ultrasound: Prostatic Biopsy with Special Techniques (Saturation, Template)
10. Prostatic Carcinoma
11. The Seminal Vesicles: Normal and Pathological Pictures
12. Benign Prostatic Hypertrophy
13. Prostate and Seminal Vesicles: Ultrasound Anatomy and Scanning Methods
14. Transrectal Saturation Biopsy
15. Clinical Reliability of the 2004 WHO Histological Classification System Compared With the 1973 WHO System for Ta Primary Bladder Tumors
16. Random biopsy: when, how many and where to take the cores?
17. MP45-08 ACTIVE SURVEILLANCE FOR SMALL RENAL MASSES: A PROSPECTIVE NON-RANDOMIZED MULTIINSTITUTIONAL STUDY (NCT03804320)
18. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
19. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU)
20. Does Educational Status Affect a Patient's Behavior Toward Erectile Dysfunction?
21. Corrigendum re 'Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study' (European Urology (2012) 62(5) (797–802), (S0302283812006082) (10.1016/j.eururo.2012.05.032))
22. Overview of the italian experience in surgical management of bladder cancer during first month of COVID-19 pandemic
23. Transrectal Saturation Biopsy
24. Diagnosis and Treatment of the Circumcaval Ureter
25. A Critical Analysis of Permixon™ in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement
26. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy
27. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy
28. Surgical Management of Bladder Cancer During First Month of COVID-19 Outbreak: Lessons Learned Across Italy
29. Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
30. Is extended and saturation biopsy necessary?
31. EARLY FEMINIZING GENITOPLASTY: SEXUAL FUNCTION IN ADULT LIFE: 265
32. Linee Guida AIRO-AIRB 2018: Neoplasie della Vescica [AIRO-AIRB Guidelines 2018: Neoplasms of the Bladder]
33. Corrigendum re “Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study” [Eur Urol 2012;62:797–802]
34. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy
35. Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
36. Mesane Endometriozisinin Tanı ve Tedavisi: Güncel Durum
37. 1873 DOES THE REGIONAL LOCATION OF PELVIC LYMPH NODE INVOLVEMENT AFFECT THE LONG-TERM CSS OF MUSCLE-INVASIVE BLADDER CANCER PATIENTS?
38. 2224 HEAD-TO-HEAD COMPARISON OF PROSTATE HEALTH INDEX AND URINARY PCA3 ASSAY IN PREDICTING PROSTATE CANCER AT INITIAL OR REPEAT PROSTATE BIOPSY
39. 1618 IMPACT OF URINARY DIVERSION ON CANCER SPECIFIC-SURVIVAL IN PATIENTS WITH BLADDER CANCER AND PATHOLOGIC POSITIVE LYMPH NODES
40. A pharmacoeconomic analysis of the use of single MMC instillation in low risk NMIBC in Italy
41. When the conservative treatment in high-risk non-muscle invasive bladder cancer patients should be abandoned
42. Ureteral Endometriosis: Proposal for a Diagnostic and Therapeutic Algorithm with a Review of the Literature
43. Reply to Manish Garg, Apul Goel and Jai Prakash's Letter to the Editor re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study. Eur Urol 2012;62:797–802
44. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non–muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study
45. 1770 NEOADJUVANT SHORT-TERM INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN COMPARED TO STANDARD SCHEDULE FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER. A RANDOMIZED PHASE II STUDY
46. Diagnosis and Treatment of Bladder Endometriosis: State of the Art
47. Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art
48. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy
49. The Optimal Rebiopsy Prostatic Scheme Depends on Patient Clinical Characteristics: Results of a Recursive Partitioning Analysis Based on a 24-Core Systematic Scheme
50. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.